2-(4-cyclohexyl-2-hydroxyphenyl)propionic acid | 57568-52-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-(4-cyclohexyl-2-hydroxyphenyl)propionic acid
• 英文别名: 2-(4-Cyclohexyl-2-hydroxyphenyl)-propionsaeure；2-(4-Cyclohexyl-2-hydroxyphenyl)-propionic acid；2-(4-cyclohexyl-2-hydroxyphenyl)propanoic acid
• CAS: 57568-52-2
• 化学式: C₁₅H₂₀O₃
• 分子量: 248.322
• InChiKey: ZZTKNJGNARYFMV-UHFFFAOYSA-N

物化性质

• 沸点：
  424.6±33.0 °C(Predicted)
• 密度：
  1.161±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  2-(4-cyclohexyl-2-hydroxyphenyl)propionic acid 在 对甲苯磺酸 作用下， 以 水 、 甲苯 为溶剂， 生成 6-cyclohexyl-2,3-dihydro-3-methylbenzofuran-2-one
  参考文献：
  名称：

  Organic compounds

  摘要：

  这项发明提供了I式化合物，其中R.sub.1是1至10个碳原子的烷基，3至8个碳原子的环烷基或苯基，而R.sub.2是氢或1至4个碳原子的烷基。可用作抗炎药、退热药、镇痛药和抑制血小板聚集的药物。

  公开号：

  US04013690A1
• 作为产物：
  描述：

  2-(3-Cyclohexylphenoxy)propionsaeureethylester 在 氢氧化钾 作用下， 以 乙醇 为溶剂， 反应 4.0h， 生成 2-(4-cyclohexyl-2-hydroxyphenyl)propionic acid
  参考文献：
  名称：

  2,3-Dihydrobenzofuran-2-ones: a new class of highly potent antiinflammatory agents

  摘要：

  A series of 2,3-dihydrobenzofuran-2-one analogues of the mold metabolite wortmannin, which is a powerful antiinflammatory compound, was synthesized. Most of these compounds were tested for their ability to inhibit the carrageenin paw edema and the adjuvant-induced arthritis of the rat and for their ability to inhibit prostaglandin synthesis in vitro. Indomethacin and diclofenac were used as references. The results show that compounds bearing an alkyl or aryl group in position 6 and an additional substituent, preferably chlorine, in position 5 are very powerful antiinflammatory agents and inhibitors of prostaglandin synthesis. The most active among these compounds, 5-chloro-6-cyclohexyl-2,3-dihydrobenzofuran-2-one, was significantly more potent than diclofenac in all testing models, more powerful than indomethacin in inhibiting acute inflammation and prostaglandin synthesis, and somewhat less potent than the latter compound in the adjuvant arthritis model.

  DOI：

  10.1021/jm00144a019
• 作为试剂：
  描述：

  2-(3-cyclohexylphenoxy)propionic acid 、 水 在 汞 氩 、 silica gel 、 ethyl acetate n-hexane 、 乙酸乙酯 、 2-(4-cyclohexyl-2-hydroxyphenyl)propionic acid 作用下， 以 乙醇 为溶剂， 反应 2.0h， 生成 2-(4-cyclohexyl-2-hydroxyphenyl)propionic acid
  参考文献：
  名称：

  Organic compounds

  摘要：

  本发明提供了I式化合物，其中R1是1至10个碳原子的烷基，3至8个碳原子的环烷基或苯基，R2是氢或1至4个碳原子的烷基。该化合物可用作抗炎、退热、镇痛和抑制血小板聚集的药物。

  公开号：

  US04013690A1

文献信息

• US4013690A
  申请人：——

  公开号：US4013690A

  公开（公告）日：1977-03-22
• Organic compounds
  申请人：Sandoz Ltd.

  公开号：US04013690A1

  公开（公告）日：1977-03-22

  This invention provides compounds of formula I, ##STR1## wherein R.sub.1 is alkyl of 1 to 10 carbon atoms, cycloalkyl of 3 to 8 carbon atoms or phenyl, and R.sub.2 is hydrogen or alkyl of 1 to 4 carbon atoms, Useful as anti-phlogistics, anti-pyretics, analagesics and inhibitors of blood platelet aggregation.

  这项发明提供了I式化合物，其中R.sub.1是1至10个碳原子的烷基，3至8个碳原子的环烷基或苯基，而R.sub.2是氢或1至4个碳原子的烷基。可用作抗炎药、退热药、镇痛药和抑制血小板聚集的药物。
• 2,3-Dihydrobenzofuran-2-ones: a new class of highly potent antiinflammatory agents
  作者：Annemarie Closse、Walter Haefliger、Daniel Hauser、Hans Ulrich Gubler、Beatrice Dewald、Marco Baggiolini

  DOI：10.1021/jm00144a019

  日期：1981.12

  A series of 2,3-dihydrobenzofuran-2-one analogues of the mold metabolite wortmannin, which is a powerful antiinflammatory compound, was synthesized. Most of these compounds were tested for their ability to inhibit the carrageenin paw edema and the adjuvant-induced arthritis of the rat and for their ability to inhibit prostaglandin synthesis in vitro. Indomethacin and diclofenac were used as references. The results show that compounds bearing an alkyl or aryl group in position 6 and an additional substituent, preferably chlorine, in position 5 are very powerful antiinflammatory agents and inhibitors of prostaglandin synthesis. The most active among these compounds, 5-chloro-6-cyclohexyl-2,3-dihydrobenzofuran-2-one, was significantly more potent than diclofenac in all testing models, more powerful than indomethacin in inhibiting acute inflammation and prostaglandin synthesis, and somewhat less potent than the latter compound in the adjuvant arthritis model.